Standard Operating Procedure: Malaria Clinical Management and Control

This Standard Operating Procedure (SOP) outlines the clinical management, diagnostic protocols, and preventive measures for malaria. Malaria remains a life-threatening disease caused by Plasmodium parasites transmitted through the bite of infected Anopheles mosquitoes. This document is designed for healthcare facilities to ensure standardized, evidence-based care, rapid diagnostic accuracy, and effective reporting to mitigate mortality and curb local transmission.

1. Initial Assessment and Triage

• Perform rapid assessment of ABCs (Airway, Breathing, Circulation) immediately upon patient presentation.
• Document clinical history, focusing on fever onset, recent travel to malaria-endemic regions, and previous malaria episodes.
• Assess for danger signs of severe malaria: inability to drink/breastfeed, vomiting, lethargy/coma, convulsions, dark urine, or respiratory distress.
• Obtain baseline vitals: Temperature, Heart Rate, Respiratory Rate, and Oxygen Saturation.
• Assign triage category based on urgency (e.g., immediate stabilization for suspected severe cases).

2. Diagnostic Testing Protocol

• Rapid Diagnostic Test (RDT): Perform an HRP2 or pLDH-based RDT for all patients presenting with fever within 30 minutes of triage.
• Microscopy: If RDT is negative but clinical suspicion remains high, prepare thick and thin blood films.
• Parasite Quantification: For positive microscopy results, calculate parasite density (parasites/µL).
• Anemia Screening: Perform a Hemoglobin (Hb) or Hematocrit (Hct) count as part of the baseline blood work.
• Documentation: Record test results in the patient chart and the facility’s Malaria Registry immediately.

3. Clinical Management and Treatment

• Uncomplicated Malaria: Administer weight-based Artemisinin-based Combination Therapy (ACT), such as Artemether-Lumefantrine, as per current national treatment guidelines.
• Severe Malaria: Initiate parenteral therapy (Intravenous Artesunate) immediately. Follow with a full course of oral ACT once the patient is able to tolerate oral medication.
• Supportive Care: Provide antipyretics for fever control, ensure adequate hydration, and monitor blood glucose levels (as hypoglycemia is a common complication of severe malaria and quinine treatment).
• Monitoring: Perform nursing rounds every 4 hours for the first 24 hours to monitor for neurological status and respiratory changes.

4. Public Health Reporting and Prevention

• Case Notification: Report all laboratory-confirmed malaria cases to the local health authority within 24 hours.
• Vector Control: Advise patients on the use of Insecticide-Treated Nets (ITNs) and the importance of indoor residual spraying.
• Patient Education: Ensure the patient or caregiver understands the importance of completing the full course of medication, even if symptoms subside.

Pro Tips & Pitfalls

• Pro Tip: Always consider "malaria-like" illness differentials. If a patient remains febrile after 48 hours of treatment, re-test and investigate for bacterial coinfections or drug resistance.
• Pro Tip: In children and pregnant women, malaria can progress rapidly; prioritize aggressive fluid management and rapid-acting antimalarial initiation.
• Pitfall: Do not delay treatment while waiting for laboratory confirmation if the patient presents with signs of severe malaria in a high-transmission setting.
• Pitfall: Over-reliance on RDTs; RDTs can occasionally provide false-negative results due to parasite gene deletion (HRP2/3). If the patient is critically ill and the RDT is negative, always verify with microscopy.

FAQ

Q: Can a patient be treated for malaria if the diagnostic test is negative? A: Generally, no. Guidelines emphasize "Test, Treat, Track." However, if clinical suspicion remains extremely high and other common febrile illnesses are ruled out, clinical judgment may warrant a repeat test or referral to a higher-level facility for advanced diagnostics.

Q: Why is IV Artesunate preferred over Quinine for severe malaria? A: Clinical trials (such as the SEAQUAMAT and AQUAMAT studies) demonstrated that IV Artesunate significantly reduces mortality compared to Quinine and is associated with fewer side effects, such as hypoglycemia and arrhythmias.

Q: How do we handle malaria during pregnancy? A: Malaria in pregnancy requires specific attention. Follow the WHO or national guidelines regarding the use of specific ACTs in the first trimester vs. later trimesters and ensure the patient is enrolled in intermittent preventive treatment (IPTp) programs if available.